Document is current
Any future updates will be listed below
-
Authors
Fenton, Timothy A.
Petkova, Stela P.
Adhikari, Anna
Silverman, Jill L.
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103526, P50HD103526, P50HD103526, P50HD103526)
Foundation for Angelman Syndrome Therapeutics
NIH/NINDS (R01NS097808, R01NS097808)
- License Information
-
More Information
Article History
Received: 8 March 2024
Accepted: 1 May 2025
First Online: 17 May 2025
Declarations
:
: The following IACUC was reviewed and approved by the UC Davis IACUC on April 20, 2023. Active protocols are reviewed annually.Title: Novel Testing of Therapeutics for Angelman Syndrome. Principal Investigator: Jill L. SilvermanProtocol #: 23384Institution: University of California, DavisThis institution is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International (AAALAC). This institution has an Animal Welfare Assurance on file with the Office of Laboratory Animal Welfare (OLAW). The Assurance Number is D16-00272 (A3433-01). The IACUC is constituted in accordance with U.S. Public Health Service (PHS) Animal Welfare Policy and includes a member of the public and a non-scientist.
: FAST, the MIND Institute and the NIH/NICHD IDDRC consent for the data presented herein to be publishable.
: The authors declare no competing interests.
